Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity.
about
Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular diseaseVisit-to-Visit Systolic Blood Pressure Variability and Cardiovascular Outcomes: New Data From a Real-World Korean Population.Sympathomodulatory Effects of Antihypertensive Drug Treatment.Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats.Prolonged blood pressure elevation following continuous infusion of angiotensin II-a baroreflex study in healthy humans.LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone.
P2860
Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@en
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@nl
type
label
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@en
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@nl
prefLabel
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@en
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@nl
P2093
P2860
P356
P1476
Telmisartan exerts sustained b ...... hibiting sympathetic activity.
@en
P2093
Daisuke Sueta
Hisao Ogawa
Ken Uekawa
Kensuke Toyama
MingJie Ma
Nobutaka Koibuchi
Shokei Kim-Mitsuyama
Takashi Nakagawa
Tetsuji Katayama
Yu Hasegawa
P2860
P304
P356
10.1093/AJH/HPU076
P577
2014-05-28T00:00:00Z